enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Meningococcal vaccine - Wikipedia

    en.wikipedia.org/wiki/Meningococcal_vaccine

    Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. [9] Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. [9] [10] The vaccines are between 85 and 100% effective for at least two years. [9]

  3. NmVac4-A/C/Y/W-135 - Wikipedia

    en.wikipedia.org/wiki/NmVac4-A/C/Y/W-135

    NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines .

  4. Vaccination schedule - Wikipedia

    en.wikipedia.org/wiki/Vaccination_schedule

    A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. [2]

  5. Neisseria meningitidis - Wikipedia

    en.wikipedia.org/wiki/Neisseria_meningitidis

    A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine licensed for people older than 55. MPSV4 may be used in people 2–55 years old if the MCV4 vaccines are not available or contraindicated. Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first ...

  6. Penbraya - Wikipedia

    en.wikipedia.org/wiki/Penbraya

    Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]

  7. Glaxo Initiates Dosing in Phase III Meningitis Vaccine Study

    www.aol.com/news/glaxo-initiates-dosing-phase...

    Glaxo (GSK) starts dosing with a phase III study on it 5-in-1 meningitis vaccine candidate.

  8. List of vaccine excipients - Wikipedia

    en.wikipedia.org/wiki/List_of_vaccine_excipients

    Vaccine Excipients Adenovirus vaccine: This list refers to the type 4 and type 7 adenovirus vaccine tablets licensed in the US: Acetone, alcohol, anhydrous lactose, castor oil, cellulose acetate phthalate, dextrose, D-fructose, D-mannose, FD&C Yellow #6 aluminium lake dye, fetal bovine serum, human serum albumin, magnesium stearate, micro crystalline cellulose, plasdone C, Polacrilin potassium ...

  9. Pentavalent vaccine - Wikipedia

    en.wikipedia.org/wiki/Pentavalent_vaccine

    A pentavalent vaccine combines five vaccines into one dose. Pentavalent vaccines include: DTwP-HepB-Hib vaccine, used by UNICEF in low/middle income countries; DTaP-IPV/Hib vaccine, used in the UK until 2017 (replaced by a hexavalent vaccine) DTaP-IPV-HepB vaccine, approved in the US